sufentanil has been researched along with Coronary Artery Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Franks, P; Keenan, RL; Nakatsuka, M | 1 |
1 trial(s) available for sufentanil and Coronary Artery Disease
| Article | Year |
|---|---|
A method of rapid-sequence induction using high-dose narcotics with vecuronium or vecuronium and pancuronium in patients with coronary artery disease.
Topics: Anesthetics, Combined; Coronary Artery Bypass; Coronary Artery Disease; Dose-Response Relationship, Drug; Female; Fentanyl; Heart Rate; Humans; Intubation, Intratracheal; Male; Mandibular Nerve; Middle Aged; Muscle Relaxation; Narcotics; Neuromuscular Nondepolarizing Agents; Pancuronium; Sufentanil; Time Factors; Ulnar Nerve; Vecuronium Bromide; Vocal Cords | 1988 |